National Vaccine Injury Compensation Program
[1] Compensation covers medical and legal expenses, loss of future earning capacity, and up to $250,000 for pain and suffering; a death benefit of up to $250,000 is available.In each of the cases, the panel found that the plaintiffs had failed to demonstrate a causal effect between the MMR vaccine and autism.Several claimants have attempted to bypass the VICP process with claims that thimerosal in vaccines had caused autism, but these were ultimately not successful.They have demanded medical monitoring for vaccinated children who do not show signs of autism and have filed class-action suits on behalf of parents.[16][17][13][18] Major scientific and medical bodies such as the Institute of Medicine[18] and World Health Organization,[19][20] as well as governmental agencies such as the Food and Drug Administration[21] and the CDC[22] reject any role for thimerosal in autism or other neurodevelopmental disorders.* This covers the vaccinations known by the abbreviations DT, DTaP, DTaP-HIB, DTaP-IPV, DTap-IPV-HIB, Td, Tdap Self representation is permitted, although the NVICP also pays attorneys fees out of the fund, separate from any compensation given to the petitioner.If smallpox vaccine were to be widely administered by public health authorities in response to a terrorist or other biological warfare attack, persons administering or producing the vaccine would be deemed federal employees and claims would be subject to the Federal Tort Claims Act, in which case claimants would sue the U.S. Government in the U.S. district courts, and would have the burden of proving the defendants' negligence, a much more difficult standard.Theresa and Michael Cedillo contended that thimerosal seriously weakened Michelle's immune system and prevented her body from clearing the measles virus after her vaccination at the age of fifteen months.At the outset Special Master George Hastings, Jr. said "Clearly the story of Michelle's life is a tragic one,"[36] while pledging to listen carefully to the evidence.Special Master Hastings concluded, "The overall weight of the evidence is overwhelmingly contrary to the petitioners' causation theories.
VaccinationVaccinatorVaccineVaccine trialCOVID-19 vaccine cardSmallpoxChicken poxMeasles/Mumps/RubellaInfluenzaCOVID-19Vaccine equityVaccine hesitancyVaccine misinformationAnti-vaccine activismVaccine line jumpingVaccine resistanceno-fault systemvaccine injuryU.S. Court of Federal ClaimsNational Childhood Vaccine Injury ActUnited States CongressDPT vaccineherd immunityHealth Resources and Services AdministrationDepartment of Health and Human Servicesno-faultdiphtheriatetanuspertussismeaslesrubellahepatitis BvaricellaHaemophilus influenzae type brotaviruspneumoniamedical malpracticeOmnibus Autism Proceedingautism spectrum disordersroutine childhood vaccinesare not linked toautismthimerosalU.S. Fifth Circuit Court of Appealsscientific consensusInstitute of MedicineWorld Health OrganizationFood and Drug AdministrationFiscal yearSelf representationHomeland Security ActFederal Tort Claims ActUnited States Court of Appeals for the Federal Circuitoptic neuritisMMR vaccinefibromyalgiaHib vaccinetransverse myelitishepatitis B vaccineGuillain–Barré syndromemultiple sclerosisinactivated polioencephalopathymitochondrial disorderOmnibus Autism Proceedingsimmune systemthimerosal-containing vaccines do not cause autismVaccine Damage PaymentCountermeasures Injury Compensation ProgramAbbott Laboratories5th Cir.Offit, Paul A.Artificial induction of immunityImmunizationVaccinesInfectionInoculationAdjuvantsVaccine ingredientsMathematical modellingStorageTimelineTrialsConjugateInactivatedAttenuatedHeterologousSubunit/componentPeptideVirus-like particleSyntheticTherapeuticToxoidGAVI AllianceVaccine wastagePolicyScheduleVaccines for Children ProgramAnthraxBrucellosisCholeraMeningococcusNmVac4-A/C/Y/W-135PlaguePneumococcalTuberculosisTyphoidTyphusDPT/DTwP/DTaPTd/TdapAdenovirusChikungunyarVSV-ZEBOVPandemrixHantavirusHepatitis ACervarixGardasilJapanese encephalitisRabiesSARS-CoV-2CorbevaxBharat BiotechCanSinoCoronaVacEpiVacCorona